AesRx Report issue

For profit Phase 2
Founded: Newton MA United States (2008)
Status: Acquired by Baxalta (2014) → now Takeda (2018)

Organization Overview

First Clinical Trial
2013
NCT01871142
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

AesRx, LLC